Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Weighing the Risks of AI Tools, From Demographic Bias to Privacy Violations

With Microsoft announcing a multibillion dollar investment into ChatGPT, Google launching Bard, and China’s search engine giant Baidu, Inc. entering the race with Ernie, the AI party has officially begun. More companies are integrating ChatGPT into their daily operations as the tool proves itself as flexible for a variety of use cases, and adoption…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

With Microsoft announcing a multibillion dollar investment into ChatGPT, Google launching Bard, and China’s search engine giant Baidu, Inc. entering the race with Ernie, the AI party has officially begun. More companies are integrating ChatGPT into their daily operations as the tool proves itself as flexible for a variety of use cases, and adoption is hot; the number of users on ChatGPT crossed 100 million over a month ago. However, even with all this use case validation and excitement around generative AI’s possibilities, experts are increasingly warning against the risks of AI.

Recently, the Federal Trade Commission (FTC) warned companies against making baseless claims and failing to see the risks posed by their AI-enabled products. The warning comes nearly two years after the FTC had raised concerns about the “troubling outcomes” produced by some AI tools. Here, the FTC pointed out how an algorithm in the healthcare industry was found to show racial bias. And a few years ago, Amazon found that its recruiting tool discriminated against women.

In the past, the FTC has fined Facebook billions of dollars for violating users’ privacy through its facial recognition software. Even White Castle, a hamburger chain, could face a fine worth billions of dollars for the automated collection and sharing of the biometric data of its employees without prior consent.

Scott Sereboff, the general manager for the North American for Deeping Source, a spatial analytics company that offers software for businesses to collect physical and virtual data without infringing on individual customers’ or employees’ privacy, gives his perspectives on the risks of AI and why he has been on a campaign to highlight its ethical uses.

Scott’s Thoughts:

When it comes to artificial intelligence, machine learning and the things that go with it, perhaps the key topic on which industry thought leaders should be focused is ethics and morality, and where we’re going with this and how we’re going to use it. The benefits of AI and machine learning are probably too numerous to count, but are we letting it grow past our ability to guide and shape it into something that is at least more difficult to use in a negative way. The conversations that all these industry experts should be having are around that — demystifying AI and machine learning, helping people to understand that at the end of every one of these algorithmic chains is a human who has either programmed it or categorized the data or has had a hand in determining the shaping of a database or of the AI itself. The part of this process that becomes scary is if we can write the ultimate AI for good programming in any subset (facial recognition, voice recognition), so too can a bad person write the fascist version or the apartheid version. IBM assisted the South African government in the creation of a database that was used for the suppression of black South Africans.

Now with every part of the AI development process, there’s something important consider in light of how it is or is not regulated. In the United States, we don’t really have a specified GDPR-style legislation. Illinois has an incredibly tough legislation, however and California too.

Another discussion we should really be having is about potential legal ramifications. Are you and your company protected against the potential legal trouble you can find yourself in if you reveal personal information or take personal information from a person without his/her permission? It is a legal gray area but are we paying enough attention to that topic as well?

Let’s say I’m running a multistage corporation that has front-end retail or shopping or a hospital network and I’ve got some sort of AI that is collecting data through video cameras or audio interfaces or gate analysis. The questions I must ask is: am I paying attention to whether or not this can be used to track everything back to me?

I don’t know if everyone realizes the potential danger and with what just happened in Illinois with the White Castle case, although it’s certainly — I should say, almost certainly — not going to wind up as bad as it is right now. The industry’s response to it has been one of surprise, and yet, why are they surprised?

We have spent decades watching social media become this incredibly divisive sort of societal upheaval mechanism. If we’re not careful and we don’t keep an eye on what we’re doing with artificial intelligence, it will do exactly the same thing and history will repeat itself. It’s really easy to say, ‘I’m not prejudiced. The database made me do it.’ So I would suggest that across all of the three questions you’ve asked, the key topics, important conversations, important questions, are all questions around morality and ethics.”

Article written by Aarushi Maheswhari

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one expert. Imagine publishing your whole team.

This article was produced through MarketScale. Create a free workspace and turn your own team's expertise into articles, video, and social posts. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

FDA clears UpDoc's LLM diabetes app, grants Aidoc breakthrough status as clinical AI crosses new regulatory thresholds

FDA clears UpDoc's LLM diabetes app, grants Aidoc breakthrough status as clinical AI crosses new regulatory thresholds

UpDoc has received FDA clearance for its LLM-driven diabetes management app, while Aidoc has been granted breakthrough device status for its AI-drafted radiology reports. This marks a significant milestone as clinical AI applications continue to gain regulatory approval and recognition. The advancements showcase the potential of AI in improving healthcare management and diagnostic processes.

  • 01UpDoc's diabetes management app receives FDA clearance.
  • 02Aidoc achieves breakthrough device status for AI radiology reports.
  • 03Regulatory milestones highlight AI's growing role in healthcare.

Jul 13, 2026

Cedars-Sinai's CDAIO on healthcare AI's second wave: workforce transformation, not just productivity

Cedars-Sinai's CDAIO on healthcare AI's second wave: workforce transformation, not just productivity

The chief data and AI officer at Cedars-Sinai discusses the evolving role of AI in healthcare. While the first wave of AI focused on enhancing productivity, the second wave is expected to transform job roles and the workforce structure. This shift indicates a deeper integration of AI technology in healthcare operations.

  • 01First wave of AI increased productivity in healthcare.
  • 02Second wave aims to restructure job roles.
  • 03AI will deeply integrate into healthcare operations.

Jul 13, 2026

Automation adoption gap widens in US manufacturing as medtech presses ahead

Automation adoption gap widens in US manufacturing as medtech presses ahead

Automation in US manufacturing lags, with 80% of factories lacking automation tools. In contrast, medtech manufacturers are advancing with technologies like micro-molding and ultrasonic welding. This disparity highlights a growing gap in technology adoption across different sectors.

  • 0180% of US factories have no automation.
  • 02Medtech manufacturers are investing in automation technologies.
  • 03There's an increasing divide in technology adoption across industries.

Jul 12, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512